Determining the best regulatory path for your medical device
What’s the best route to market for your medical device? Read our insights on how to balance regulatory and...
Value Proposition Matrix™ – Building successful products and services
Successful value proposition development is essential to ensure we develop successful new products and...
Future Operating Room – Understanding digital trends and uncovering impacts
Eduardo von Ristow and Ross Jones discuss the digital trends influencing the future of the operating room, potential...
Improving accessibility of advanced molecular diagnostics in precision oncology
Liquid biopsy genetic tests are making precision cancer diagnostics simpler and quicker than ever before. Using a blood...
Awards shine a light on post-pandemic healthcare innovation
Sagentia Innovation’s Rob Morgan and Paulo Pinheiro helped judge the Cambridge Independent Science and Technology...
Webinar: What’s next in women’s health?
The last five years have seen a significant increase in women’s health research and investment. Emerging technologies...
Making at-home-molecular tests affordable, actionable and sustainable
Taking diagnostic testing to patients’ homes offers many advantages for global healthcare, and progress in molecular...
Breaking the mould in microplastics
Microplastics can be found wherever we choose to look, from remote Arctic locations to marine organisms and the air we...
When should you contact FDA about a new medical device?
Medical device companies often ask us about the best time to contact FDA for regulatory guidance. There’s a delicate...
Answering C-Suite top level R&D questions to accelerate and de-risk innovation – find out how our experts deliver answers to the big questions
Sagentia Innovation’s advisory team handles big questions like these on a daily basis. Our clients’ environments...
